These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1056960)

  • 1. The immune response to infection with vaccinia virus in mice. II. Appearance of hypersensitivity, production of macrophage migration inhibitory factor and transformation of spleen cells in response to virus antigens.
    Hutt LM
    J Hyg (Lond); 1975 Jun; 74(3):315-27. PubMed ID: 1056960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sensitization against the antigens of the brain after experimental vaccinia infection. I. Evidence for cell-mediated immune response to brain-antigens (author's transl)].
    Huber HC; Zinn KH; Hochstein-Mintzel V; Simon J; Stickl H
    Zentralbl Bakteriol Orig A; 1975 Jun; 232(1):1-7. PubMed ID: 51549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction and in Vitro demonstration of cellular immunity to DNA and RNA viruses in guinea-pigs.
    Koszinowski U; Bandlow G
    Clin Exp Immunol; 1975 Apr; 20(1):143-54. PubMed ID: 173485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-T cell interaction in the in vitro induction of delayed-type hypersensitivity (DTH) responses: demonstration of vaccinia virus-reactive helper T cell activity involved in enhanced induction of DTH responses.
    Kosugi A; Takai Y; Ogata M; Fujiwara H; Hamaoka T
    J Leukoc Biol; 1985 May; 37(5):629-39. PubMed ID: 3156939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of skin resistance to vaccinia virus in rabbits by vaccinia-soluble early antigens.
    Ueda Y; Tagaya I
    J Exp Med; 1973 Nov; 138(5):1033-43. PubMed ID: 4744920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage migration inhibition as a correlate of cell-mediated immunity to herpes simplex virus type 2 in mice.
    Mogensen SC
    Immunobiology; 1982; 162(1):28-38. PubMed ID: 6286467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate immunity to viruses: control of vaccinia virus infection by gamma delta T cells.
    Selin LK; Santolucito PA; Pinto AK; Szomolanyi-Tsuda E; Welsh RM
    J Immunol; 2001 Jun; 166(11):6784-94. PubMed ID: 11359837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro stimulation of sensitized lymphocytes by herpes simplex virus and vaccinia virus.
    Rosenberg GL; Farber PA; Notkins AL
    Proc Natl Acad Sci U S A; 1972 Mar; 69(3):756-60. PubMed ID: 4335071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed hypersensitivity in vaccinia-infected mice. II. Resistance of peritoneal macrophages against vaccinia infection.
    Ueda S; Nozima T
    Acta Virol; 1973 Jan; 17(1):41-9. PubMed ID: 4405395
    [No Abstract]   [Full Text] [Related]  

  • 10. T-T cell interaction in the induction of delayed-type hypersensitivity (DTH) responses: vaccinia virus-reactive helper T cell activity involved in enhanced in vivo induction of DTH responses and its application to augmentation of tumor-specific DTH responses.
    Takai Y; Kosugi A; Yoshioka T; Tomita S; Fujiwara H; Hamaoka T
    J Immunol; 1985 Jan; 134(1):108-13. PubMed ID: 3155458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective increase in lymphocyte interferon response to vaccinia antigen after revaccination.
    Epstein LB; Stevens DA; Merigan TC
    Proc Natl Acad Sci U S A; 1972 Sep; 69(9):2632-6. PubMed ID: 4506785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immune response to infection with vaccinia virus in mice. I. Infection and the production of antibody neutralizing cell-associated and cell-free virus.
    Hutt LM
    J Hyg (Lond); 1975 Jun; 74(3):301-14. PubMed ID: 168248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. I. Model and viral specificity1.
    Wong CY; Woodruff JJ; Woodruff JF
    J Immunol; 1977 Apr; 118(4):1159-64. PubMed ID: 300399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte and macrophage responses after vaccinia virus infections.
    McLaren C; Cheng H; Spicer DL; Tompkins WA
    Infect Immun; 1976 Oct; 14(4):1014-21. PubMed ID: 992867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CD8 T cell response to vaccinia virus exhibits site-dependent heterogeneity of functional responses.
    Xiao Z; Curtsinger JM; Prlic M; Jameson SC; Mescher MF
    Int Immunol; 2007 Jun; 19(6):733-43. PubMed ID: 17545279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage immunity to vaccina virus: factors affecting macrophage immunity in vitro.
    Schultz RM; Woan MC; Tompkins WA
    J Reticuloendothel Soc; 1974 Jul; 16(1):37-47. PubMed ID: 4137839
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of transfer factor on lymphocyte function in anergic patients.
    Kirkpatrick CH; Rich RR; Smith TK
    J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of delayed hypersensitivity of guinea pigs to vaccinia virus. Comparison of inhibition of cell migration to a local passive transfer reaction for the quantification of delayed hypersensitivity.
    Pilchard EI; Gold EE; Gray HK
    Int Arch Allergy Appl Immunol; 1970; 37(4):337-43. PubMed ID: 4903805
    [No Abstract]   [Full Text] [Related]  

  • 19. Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance.
    Actor JK; Shirai M; Kullberg MC; Buller RM; Sher A; Berzofsky JA
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):948-52. PubMed ID: 8094248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target cell-dependent T cell-mediated lysis of vaccinia virus-infected cells.
    Koszinowski U; Thomssen R
    Eur J Immunol; 1975 Apr; 5(4):245-51. PubMed ID: 1086229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.